Study Highlights Link Between Fosamax and Nonhealing Femur Fractures

May 24, 2014
by Adler Markoff & Associates

Request A Free Consultation

(405) 607-8757

    Study Highlights Link Between Fosamax and Nonhealing Femur Fractures

    Researchers involved in a study published last month in the Journal of Bone & Joint Surgery have indicated that they have found a causal link between the osteoporosis drug Fosamax and nonhealing femur fractures. The study findings provide further support for the lawsuits filed on behalf of hundreds of former Fosamax users who have suffered from devastating complications following an atypical femur fracture. If you have suffered an atypical femur fracture or another serious injury that you believe to have been caused by the bisphosphonate drug Fosamax, our reputable lawyers at AMA Law can help. With our experienced attorneys on your side, you can hold the allegedly negligent drug maker liable for its dangerous medication and seek fair and timely reimbursement for your injuries.


    The study, funded in part by the National Institutes of Health, looked at the U.S. Food and Drug Administration (FDA)’s adverse event reporting system, and determined that rare and nonhealing femur fractures are not just associated with taking bisphosphonate drugs like Fosamax, but are directly caused by the widely used medications. Fosamax (alendronate sodium) is one of the most popular osteoporosis drugs on the market today, and has been available in the United States since it was introduced by Merck in 1995 for the treatment and prevention of osteoporosis.


    Despite the fact that Fosamax is designed to strengthen weakened bones and reduce the risk of fractures caused by osteoporosis, long-term use of the bisphosphonate drug has been linked to an increased risk of low-trauma bone fractures. In some cases of Fosamax use, the patient may even suffer a sudden femur fracture after little or no trauma, such as when taking a step. In October 2010, following an investigation by the FDA, Merck was required to add new warnings about the risk of bone fractures to the Fosamax label, highlighting related warning signs like hip or groin pain.


    In light of the risk of serious complications associated with the use of Fosamax, Merck currently faces about 3,000 lawsuits filed by former Fosamax users in state and federal courts nationwide. The complaints allege that Merck failed to provide adequate warnings about the risks patients face with long-term use of the osteoporosis medication. If you took Fosamax and you have since experienced a devastating side effect like an unexpected femur fracture, contact our knowledgeable attorneys at AMA Law for legal help. Our lawyers have experience protecting the rights of consumers harmed by pharmaceutical drugs, and will work diligently to help you pursue the compensation you deserve for your injuries.

    Request a free consultation

    (405) 607-8757